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and X4) and dihydromonacolin L4) are metabolites of Monascus ruber. These compounds specifically inhibit 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase, the rate-limiting enzyme in cholesterol synthetic pathway. In the present study, another metabolite of monacolin group, designated monacolin M (Fig. 1, 1 ) was isolated from cultures of a strain of M. ruber. Its physical and chemical properties and biological activity were also studied.
Materials and Methods

Microbial Strain
Monascus ruber M4681 was employed in the present study. This strain was found to produce 1 as the minor metabolite, along with monacolins J, K and L.
Biological Assays HMG-CoA reductase was assayed as described previously using rat liver enzyme preparations).
Fermentation and Isolation of Monacolin M M. ruber M4681 was grown aerobically at 25°C for 10 days in a medium containing glycerol 7 %, glucose 3 %, meat extract 3 %, peptone 0.8 %, NaNO3 0.2 % and MgSO4 • 7H2O 0.1 % (pH 5). Under these conditions, this strain produced approximately 20 ug/ml of monacolin M. Culture filtrate (10 liters) was extracted at pH 6 with dichloromethane (5 liters). The water layer was pooled, adjusted to pH 2 with trifluoroacetic acid and extracted twice with 6 liters of ethyl acetate. The solvent layer was dried over Na2SO4 and evaporated to dryness. The residue (8.6 g) was submitted to silica gel column chromatography (Wako gel C-200, 3x42 cm). The column was developed with a solvent system of n-hexane -acetone (9: 1 and 9:2) and fractions containing 1 were combined and evaporated to dryness, yielding 110 mg of solids. The solids were submitted to HPLC on Silica ODS column (Nihon Bunko) by using a solvent mixture of acetonitrile -water (45: 55), yielding 8 mg of powder. This powder was further purified by HPLC on the Silica ODS column developed with a mixture of dichloromethane -2-propanol (97: 3) and 2 mg of purified 1 was obtained.
Results and Discussion
Mass spectral analyses (CI (chemical ionization)-MS
and FD (field desorption)-MS) established VOL. XXXIX NO. 12 THE JOURNAL OF ANTIBIOTICS molecular weight and elemental composition of 1 for 406 and C23H34O6 (calcd 406.518), respectively.
UV spectrum in methanol was identical to those of 2 and 322.3.6). IR spectrum (KBr) ( cm-1 
tion of the latter proton.
Based on the above information, we assumed the structure of monacolin M as that shown in Fig. 1 (1) . The absolute configulation of the hydroxyl group on the side chain was not determined in the present experiments.
On the bases of the data for complete assignment of 1H and 13C NMR of 3, together with those for R-hydroxybutyrate ethyl ester (Fig. 4) , protons and carbons of 1 were assigned as shown in Tables   I and 2 .
Monacolin M inhibited HMG-CoA reductase activity by 50% at a concentration of 2.9 'Um. Under the same conditions, monacolin K inhibited reductase activity by 50% at 0.8 Itm.
Of the three metabolites, monacolins J, K and L, monacolin L is first synthesized from 9 molecules of acetate, which is converted to monacolin J by hydroxylation. Monacolin K is then derived from monacolin J7). a-Methyl-~-ketobutyryl ester of monacolin J (monacolin X) is accumulated in the culture of a mutant strain of M. ruber that produces no detectable amount of monacolin K. Inversely, the parental strain produces monacolin K, while no monacolin X is detectable in its culture).
These observations suggest that monacolin J is converted to monacolin X which is then transformed to monacolin K. Further, it is likely from their structure that monacolin M is derived from monacolin J via a synthetic pathway distinct from that for monacolins X and K.
